CCL14 Predicts Oliguria and Dialysis Requirement in Patients with Moderate to Severe Acute Kidney Injury
Blood Purification · 2024
DOI: 10.1159/000538898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Purification, 2024. Verfasst von Sevag Demirjian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Acute Kidney Injury, Oliguria, Renal Dialysis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
AKI is a frequent complication of critical illness and portends poor outcome. CCL14 is a validated predictor of persistent severe AKI in critically ill patients. We examined the association of CCL14 with urine output within 48 h.
Methods
In pooled data from 2 studies of critically ill patients with KDIGO stage 2–3 AKI, CCL14 was measured by NEPHROCLEAR™ CCL14 Test on the Astute 140® Meter (low, intermediate, and high categories [1.3 and 13 ng/mL]). Average hourly urine output over 48 h, stage 3 AKI per urine output criterion on day 2, and composite of dialysis or death within 7 days were examined using multivariable mixed and logistic regression models.
Results
Of the 497 subjects with median age of 65 (56–74) years, 49% (242/497) were on diuretics. CCL14 concentration was low in 219 (44%), intermediate in 217 (44%), and high in 61 (12%) patients. In mixed regression analysis, hourly urine output over time was different within each CCL14 risk category based on diuretic use due to significant three-way interaction (p < 0.001). In logistic regression analysis, CCL14 risk category was independently associated with low urine output on day 2 per KDIGO stage 3 (adjusted for diuretic use and baseline clinical variables), and composite of dialysis or death within 7 days (adjusted for urine output within 48 h of CCL14 measurement).
Conclusions
CCL14 measured in patients with moderate to severe AKI is associated with urine output trajectory within 48 h, oliguria on day 2, and dialysis within 7 days.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Kidney Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
- Department of Medicine, Veterans Affairs Medical Center, San Diego, California, USA.
- Departments of Anesthesiology and Critical Care Medicine, George Washington University, Washington, District of Columbia, USA.
- Department of Intensive Care, Royal Surrey Hospital, Guildford, UK.
- Department of Clinical and Experimental Medicine, Faculty of Health Sciences, University of Surrey, Guildford, UK.
- Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Zitieren
APA
Demirjian, S., Chawla, L., Davison, D., Forni, L. G., Heung, M., Hoste, E. A. J., Koyner, J., Kampf, J. P., Kwan, T., McPherson, P., & Kellum, J. A. (2024). CCL14 Predicts Oliguria and Dialysis Requirement in Patients with Moderate to Severe Acute Kidney Injury. Blood Purification. https://doi.org/10.1159/000538898
Vancouver
Demirjian S, Chawla L, Davison D, Forni LG, Heung M, Hoste EAJ, et al. CCL14 Predicts Oliguria and Dialysis Requirement in Patients with Moderate to Severe Acute Kidney Injury. Blood Purification. 2024. doi:10.1159/000538898
BibTeX
@article{Demirjian2024,
author = {Demirjian, Sevag and Chawla, Lakhmir and Davison, Danielle and Forni, Lui G and Heung, Michael and Hoste, Eric A J and Koyner, Jay and Kampf, J Patrick and Kwan, Thomas and McPherson, Paul and Kellum, John A},
title = {CCL14 Predicts Oliguria and Dialysis Requirement in Patients with Moderate to Severe Acute Kidney Injury},
journal = {Blood Purification},
year = {2024},
doi = {10.1159/000538898}
}
EUVIMED